Literature DB >> 1403409

Cadaveric renal allograft rejection after treatment with recombinant human growth hormone.

I D Schwartz, B A Warady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403409     DOI: 10.1016/s0022-3476(05)81171-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry.

Authors:  Richard N Fine; Donald Stablein
Journal:  Pediatr Nephrol       Date:  2005-01-29       Impact factor: 3.714

2.  Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 3.  Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.

Authors:  Tim Ulinski; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2006-05-10       Impact factor: 3.714

Review 4.  Effects of growth hormone on kidney function in pediatric transplant recipients.

Authors:  B M Chavers; L Doherty; T E Nevins; M Cook; K Sane
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

5.  "Low-dose" growth hormone therapy during peritoneal dialysis or following renal transplantation.

Authors:  I D Schwartz; B A Warady; C L Buchanan; L Reed; L M Hussey; C P Howard; S Hellerstein; J A Grunt
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.